-
Seagate Collaborates With eBay to Boost Sustainability
2024 Jun 19, 1:14pm | 745Seagate Technology Holdings plc (NASDAQ: STX) is collaborating with eBay to set up its storefront on the latter's e-commerce platform. The storefront on eBay (NASDAQ: EBAY) will establish a direct channel for STX's consumers to gain access to "factory-recertified" hard drives...
-
La-Z-Boy Q4 Earnings and Sales Beat Estimates, Down Y/Y
2024 Jun 18, 3:50pm | 1020La-Z-Boy Incorporated (NYSE: LZB) reported better than expected fourth-quarter fiscal 2024 (ended Apr 27, 2024) results, with earnings and sales surpassing the Zacks Consensus Estimate. The metrics declined on a year-over-year basis due to reduced spending on furniture and home furnishings, with...
-
Lennar Q2 Earnings & Revenues Beat Estimates, Orders Up
2024 Jun 18, 3:50pm | 1024Lennar Corporation (NYSE: LEN) reported second-quarter fiscal 2024 results, wherein its earnings and revenues surpassed the Zacks Consensus Estimate. On a year-over-year basis, both the top and bottom lines increased, given the company's emphasis on maintaining a steady production rate to drive...
-
Here's Why You Should Stay Invested in AXIS Capital
2024 Jun 18, 2:55pm | 835AXIS Capital Holdings Limited (NYSE: AXS) is poised to gain from its compelling and diversified product portfolio, underwriting excellence, digital capabilities and solid capital position. These, along with solid growth projections, make the stock worth retaining. This leading specialty insurer and...
-
Compelling Reasons to Hold on to Cigna Stock for Now
2024 Jun 18, 1:18pm | 934The Cigna Group (NYSE: CI) continues to be aided by two solid growth platforms, acquisitions and a solid financial position. A solid 2024 guidance also acts as an additional tailwind for the stock. Zacks Rank & Price Performance Cigna carries a Zacks Rank #3 (Hold), at present. The stock...
-
Tyler Technologies Rides on Growing Customer Base
2024 Jun 17, 3:57pm | 772Tyler Technologies (NYSE: TYL) has gained 12.8% year to date against the Zacks Business - Software Services Industry's decline of 5.4%. TYL's price rise reflects investors' confidence in the company's impressive financial results in consecutive quarters, strong fundamentals and an...
-
Tech ETFs Faceoff: Apple Vs Microsoft
2024 Jun 17, 3:40pm | 901The technology sector has been the clear leader of the 2024 market rally so far, driven by the artificial intelligence craze, hopes of rate cuts and the rising share of the "Magnificent Seven". The "Magnificent Seven" is the biggest engine of growth for the technology sector. In...
-
Zimmer Biomet Advances in GenAI Technology With RevelAi
2024 Jun 14, 1:47pm | 883Zimmer Biomet (NYSE: ZBH) and RevelAi Health accepted a multi-year co-marketing agreement to commercialize generative artificial intelligence-powered engagement solutions, which, in turn, should help the advancement of value-based orthopedic care and health equity. The partnership is aimed at...
-
Haemonetics Banks on Growing Plasma Arm, Innovation
2024 Jun 13, 3:41pm | 969Haemonetics (NYSE: HAE) has been gaining from business growth within Plasma, Hospital and Hemostasis Management. Its new launches also aid growth. The stock carries a Zacks Rank #1 (Strong Buy) currently. Haemonetics' Plasma revenues grew 6% in the fourth quarter of fiscal 2024, driven...
-
Abbott Gets FDA Nod for Two Glucose Monitoring Systems
2024 Jun 13, 1:05pm | 1018Abbott (NYSE: ABT) announced that Lingo and Libre Rio, two of its glucose monitoring system, have received FDA clearance. Lingo and Libre Rio are based on Abbott's own Freestyle Libre continuous glucose monitoring (CGM) technology. The latest development is expected to expand the company's...
-
Ultragenyx Posts New Data From Bone Disease Study
2024 Jun 13, 1:03pm | 838Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), along with partner Mereo BioPharma (MREO), announced new positive 14-month data from the phase II portion of the phase II/III Orbit study evaluating setrusumab (UX143) in patients with osteogenesis imperfecta. The data showed that the large reduction...
-
Here's What to Expect From La-Z-Boy in Q4 Earnings
2024 Jun 12, 3:40pm | 816La-Z-Boy Incorporated (NYSE: LZB) is slated to report its fourth-quarter fiscal 2024 earnings on Jun 17, after market close. In the last reported quarter, the company's earnings per share of 67 cents missed the Zacks Consensus Estimate of 75 cents and declined from the year-ago figure of 91...
-
Capricor Advances in DMD Therapy With Positive Study Data
2024 Jun 10, 3:54pm | 738Capricor Therapeutics (NASDAQ: CAPR), a biotechnology firm focused on innovative therapies for rare diseases, has announced favorable three-year results from the ongoing HOPE-2 open-label extension (OLE) study on CAP-1002 for Duchenne muscular dystrophy. Patients treated with CAP-1002 showed...
-
Virco Manufacturing Corporation Beats Q1 Earnings and Revenue Estimates
2024 Jun 07, 3:48pm | 645Virco Manufacturing Corporation (NASDAQ: VIRC) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report...
-
The J.M. Smucker Up on Q4 Earnings Beat, Higher Volumes
2024 Jun 07, 3:42pm | 1032The J. M. Smucker Company (NYSE: SJM) posted fourth-quarter fiscal 2024 results, wherein the bottom line increased year over year and beat the Zacks Consensus Estimate. While the top line declined, the company witnessed an increase in comparable net sales due to the higher volume/mix and net price...
Coverage of Earnings Beats.